VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $505,000 | +10.3% | 40,000 | -20.0% | 0.02% | -12.0% |
| Q1 2020 | $458,000 | -66.3% | 50,000 | 0.0% | 0.02% | -60.3% |
| Q2 2019 | $1,361,000 | -62.6% | 50,000 | -73.7% | 0.06% | -62.5% |
| Q1 2019 | $3,635,000 | +103.6% | 189,927 | 0.0% | 0.17% | +95.3% |
| Q4 2018 | $1,785,000 | -47.6% | 189,927 | +5.6% | 0.09% | -44.2% |
| Q3 2018 | $3,404,000 | -0.4% | 179,927 | +2.9% | 0.15% | +14.1% |
| Q2 2018 | $3,418,000 | +4.0% | 174,927 | 0.0% | 0.14% | +1.5% |
| Q1 2018 | $3,287,000 | -25.3% | 174,927 | -34.0% | 0.13% | -21.3% |
| Q4 2017 | $4,398,000 | +29.5% | 264,927 | +60.6% | 0.17% | +32.0% |
| Q3 2017 | $3,396,000 | +110.5% | 164,927 | -8.4% | 0.13% | +120.7% |
| Q2 2017 | $1,613,000 | +10.8% | 180,000 | +63.6% | 0.06% | +18.4% |
| Q1 2017 | $1,456,000 | +14.3% | 110,000 | +10.0% | 0.05% | +4.3% |
| Q4 2016 | $1,274,000 | – | 100,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |